Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q72288126)
Watch
English
Five-year results of a phase II study with low-dose bacille Calmette-Guerin therapy in high-risk superficial bladder cancer
scientific article published on 01 June 1995
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
title
Five-year results of a phase II study with low-dose bacille Calmette-Guerin therapy in high-risk superficial bladder cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
main subject
bladder cancer
1 reference
based on heuristic
inferred from title
author name string
D Mack
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
J Frick
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
language of work or name
English
0 references
publication date
1 June 1995
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
published in
Urology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
volume
45
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
issue
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
page(s)
958-961
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
cites work
Superficial bladder cancer: progression and recurrence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of intravesical bacillus calmette-guerin (BCG) on carcinomain situ of the bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bacillus Calmette-Guerin for treatment of superficial transitional cell carcinoma of the bladder in patients who have failed thiotepa and/or mitomycin C
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Single course versus maintenance bacillus Calmette-Guerin therapy for superficial bladder tumors: a prospective, randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term followup of patients treated with 1 or 2, 6-week courses of intravesical bacillus Calmette-Guerin: analysis of possible predictors of response free of tumor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0090-4295%2899%2980115-0
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0090-4295(99)80115-0
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
PubMed publication ID
7771030
1 reference
stated in
Europe PubMed Central
PubMed publication ID
7771030
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7771030%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
